Dr. Jagasia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605- Is this information wrong?
Summary
- Dr. Madan Jagasia is an oncologist in Nashville, TN and is affiliated with multiple hospitals in the area, including Vanderbilt University Medical Center and Tennessee Valley Healthcare System. He received his medical degree from Seth G.S. Medical College and has been in practice 28 years. He also speaks multiple languages, including Hindi. He specializes in hematologic oncology and is experienced in hematologic oncology and stem cell transplantation, with a research focus on Graft-versus-host disease
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
- Methodist Hospitals of Memphis-CentralResidency, Internal Medicine, 1994 - 1996
- Nassau University Medical CenterInternship, Internal Medicine, 1993 - 1994
- Seth G.S. Medical CollegeClass of 1989
Certifications & Licensure
- TN State Medical License 1997 - 2025
- AL State Medical License 2020 - 2020
- AR State Medical License 1995 - 2001
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens Start of enrollment: 2006 Jul 01
- Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients Start of enrollment: 2007 Dec 01
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder Start of enrollment: 2008 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsInterrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease.Shramana Ghosh, Laura Baker, Fuyao Chen, Zain Khera, Arved Vain, Kathy Zhang, Alexis Hood, Hayden Smith, Heidi Chen, Madan Jagasia, Eric Tkaczyk> ;Archives of Dermatological Research. 2023 Nov 1
- 6 citationsPaving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions...Sarah Nikiforow, Matthew J Frigault, Noelle V Frey, Rebecca A Gardner, Krishna V Komanduri, Miguel-Angel Perales, Partow Kebriaei, Phyllis Irene Warkentin, Marcelo Pas...> ;Transplantation and Cellular Therapy. 2023 Apr 1
- 8 citationsAxatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.Carrie L Kitko, Mukta Arora, Zachariah DeFilipp, Mohammad Abu Zaid, Antonio Di Stasi, Vedran Radojcic, Courtney B Betts, Lisa M Coussens, Michael L Meyers, Hope Qamoos...> ;Journal of Clinical Oncology. 2023 Apr 1
- Join now to see all
Lectures
- Prospective Study of Apixaban for Primary Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Prospective Outcomes of Second Line Therapy in Acute Gvhd: Six Month Freedom from Treatment Failure and Day 28 Response in a Multicentre Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Ruxolitinib Improves Outcomes in Patients with Steroid-Refractory Graft-Versus-Host DiseaseJune 1st, 2020
- MaaT Pharma Announces Formation of Its GvHD-Focused Scientific Advisory Board to Support Development of Microbiome Restoration Therapeutics in Hemato-Oncological IndicationsMay 12th, 2020
- Longer Looks: Public Housing, Small Pox Experts, Climate Change in the Time of Coronavirus, and MoreMarch 27th, 2020
- Join now to see all
Professional Memberships
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: